Physician

Himanshu Aggarwal, M.D., M.S.

According to 2025 Medicare claims, Himanshu Aggarwal, M.D., M.S. (NPI: 1316106164) practices urology in the Montgomery, AL market, with the plurality of this provider's patient population coming from Montgomery, AL. This provider's primary affiliated billing organization is JACKSON HOSPITAL AND CLINIC, INC. (NPI: 1205494416; TIN: 63-6001820) and primary practice location at 36106-1160. Aggarwal is affiliated with the CHSPSC ACO 12, LLC (ACO ID: A3722), participating under the MSSP model.

Aggarwal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 691 traditional Medicare patients, billed 2,890 HCPCS/CPT codes, and received $213,396 in Medicare payments. The top billing code was 51728 (Complex measurement of pressure of urine flow in bladder with voiding pressure studies). Part D data shows 5,289 prescription claims across 1,327 beneficiaries totaling $672,200 in drug costs, led by Gemtesa (Vibegron). DME data shows 70 claims. Open Payments data shows 47 records totaling $9,694. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $57,796 to $213,396. Similarly, Part D prescription costs have moved sharply higher in recent years, from $417 to $672,200. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $226 and ending at $668.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	127	875	$57,796
2017	318	2,844	$161,553
2018	191	1,489	$56,281
2019	348	1,467	$136,533
2020	383	2,276	$203,315
2021	482	2,720	$253,544
2022	579	3,068	$280,393
2023	617	2,810	$220,953
2024	691	2,890	$213,396

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	12	$417
2016	55	111	$8,751
2017	205	735	$78,675
2018	231	701	$70,810
2019	358	1,000	$105,411
2020	441	1,718	$177,009
2021	633	2,370	$271,334
2022	849	3,034	$402,634
2023	1,047	3,839	$470,985
2024	1,327	5,289	$672,200

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	72	$8,663
2021	11	69	$7,724
2022	15	72	$9,118
2023	19	142	$29,579
2024	12	70	$19,886

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
51728	Complex measurement of pressure of urine flow in bladder with voiding pressure studies	195	197	$69
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	492	779	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	226	252	$40
51797	Insertion of device into abdomen with pressure and urine flow rate study	195	197	$27
51784	Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings	200	203	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	435	17,566	$278,385
Myrbetriq	Mirabegron	347	14,700	$216,828
Estradiol	Estradiol	669	62,473	$57,370
Methenamine Hippurate	Methenamine Hippurate	594	21,634	$37,331
Tamsulosin Hcl	Tamsulosin Hcl	884	60,181	$9,189

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	12	57	$14,718
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	13	$5,169

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$9,694	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Himanshu Aggarwal, M.D., M.S.?

Tedicare shows public-source Medicare data for Himanshu Aggarwal, M.D., M.S. (NPI 1316106164), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Himanshu Aggarwal, M.D., M.S. have ACO affiliation data?

Himanshu Aggarwal, M.D., M.S. is shown with ACO affiliation data for CHSPSC ACO 12, LLC (MSSP, ACO ID A3722).

What billing organization is linked to Himanshu Aggarwal, M.D., M.S.?

Himanshu Aggarwal, M.D., M.S. is linked to JACKSON HOSPITAL AND CLINIC, INC. (billing NPI 1205494416) in the available physician profile data.

Does Himanshu Aggarwal, M.D., M.S. have Open Payments data?

Himanshu Aggarwal, M.D., M.S. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.